Has participated in:
-
Fibrosis remodelling and ECM biomarkers in liver fibrosis
-
The calcium-activated potassium channel KCa3.1 is an important modulator of hepatic injury
-
The Specific NLRP3 Antagonist IFM-514 Decreases Fibrosis and Inflammation in Experimental Murine Non-Alcoholic Steatohepatitis
-
Novel Targets and Drug Development in Portal Hypertension